Letters | Sunday, 16 August 2009

PRINT THIS ARTICLE

Generics on the Maltese market

In the article ‘Medicines in Malta 40% more expensive than Europe’ of 12 August, it was stated that there are no generics of Alendronate, a medicine used for osteoporosis, on the Maltese market.
We would like to inform you that thanks to Arrow Generics, a company which invests heavily in Malta, the local population benefits from the availability of the generic of Alendronate. This has been on the market for the past eighteen months.
The introduction of Arrow’s alendronic acid has enhanced compliance, meaning that patients adhere to the treatment, as price does not hinder them from continuing this necessary treatment.

Ishmael Dalli
Medical Representative
Vivian Corporation

Any comments?
If you wish your comments to be published in our Letters pages please click button below.
Please write a contact number and a postal address where you may be contacted.

All the interviews from Reporter on MaltaToday's YouTube channel.

EDITORIAL


Better regulation is better governance

INTERVIEW


A midsummer’s nightmare?

OPINIONS

Saviour Balzan
The last remaining steps to Paradise… lost

Evarist Bartolo
Notes from a dossier, and why Mizzi was not bluffing

Michael Falzon:
In planning, only good laws can be enforced

Claudine Cassar
Our human destructive genius is hard at work